跳至主要内容
临床试验/NCT03976557
NCT03976557终止不适用

Implementation and Evaluation of BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden. Study Protocol

Bactiguard AB2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2019年4月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Bactiguard AB
入组人数
19
试验地点
2
主要终点
Number of patients with catheter related complications

研究概览

简要总结

Primary objective of the study is to establish the incidence of all any catheter related complications in BIP CVC and standard CVC groups in patients requiring CVC.

(CVC - Central Venous Catheter; BIP - Bactiguard Infection Protection)

详细描述

Catheter related complications include CRBSI, CRI, Local CVC infection, need to exchange of CVC due to suspected CRI/CRBSI or thrombosis, stop / slower flow in any CVC lumen, local thrombosis, device malfunctions / technical catheter problems, device related adverse events.

(CRBSI - Catheter Related Blood Stream Infection; CRI - Catheter Related Infection)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to the Access Center at Danderyd who need an elective CVC (surgery, infection, nutrition, medication...)
  • Fully recognize and understand patient information
  • Signed informed consent

排除标准

  • If CVC present prior to inclusion in the study and no intention to change the present CVC over guidewire
  • Age < 18 years
  • Pregnant women
  • Known allergy to gold, silver and palladium
  • Participation in other clinical studies which may interfere with this study as judged by the Investigator

结局指标

主要结局

Number of patients with catheter related complications

时间窗: From CVC insertion until CVC withdrawal

Patients having any complication specified as secondary endpoints

次要结局

  • Number of patients with stop or slower flow in any CVC lumen(From CVC insertion until CVC withdrawal)
  • Number of patients with device malfunctions(From CVC insertion until CVC withdrawal)
  • Number of patients with local thrombosis(From CVC insertion until CVC withdrawal)
  • Number of patients with adverse events(From CVC insertion until CVC withdrawal)
  • Number of patients with CRI(From CVC insertion until CVC withdrawal)
  • Number of patients with CRBSI(From CVC insertion until CVC withdrawal)
  • Number of CVC exchanges per patient due to suspected infection or thrombosis(From CVC insertion until CVC withdrawal)
  • Number of patients with local CVC infections(From CVC insertion until CVC withdrawal)
  • Number of patients with antibiotics and antithrombotics drug use(From CVC insertion until CVC withdrawal)

研究者

发起方
Bactiguard AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验